Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To explore effectiveness of procalcitonin-guided antibiotic therapy in acute exacerbations of bronchiectasis, and to explore the clinical value of procalcitonin in bronchiectasis.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Procalcitonin-guided antibiotic treatment group | Experimental | Patients were divided into 2 subgroups:
|
|
| Standard antibiotic therapy group | Active Comparator | The application of antibiotics is given to patiens according to the doctor's experience. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Procalcitonin | Other | The application of antimicrobial agents is determined by PCT results. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Antimicrobial prescription rate | 14 days | |
| Number of days of antimicrobial application | 14 days | |
| The number of days in hospital | 14 days |
| Measure | Description | Time Frame |
|---|---|---|
| Effective rate of clinical treatment | 14 days | |
| Quality of life score | 6 months | |
| Adverse reaction rate |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001987 | Bronchiectasis |
| ID | Term |
|---|---|
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077740 | Procalcitonin |
| ID | Term |
|---|---|
| D002116 | Calcitonin |
| D036361 | Peptide Hormones |
| D006728 | Hormones |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Clinical Experience | Other | The application of antimicrobial agents is determined by clinical experience of doctors. |
|
| 14 days |
| Bacterial resistance rate | 14 days |
| The incidence of complications | 14 days |
| fungal infection rate | 14 days |
| mortality rate | 14 days |
| The proportion of patients with at least once acute exacerbation in 6 months | 6 months |
| D010455 | Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |
| D011498 | Protein Precursors |
| D011506 | Proteins |